Jack W Callicutt insider trades
Open-market stock purchases and sales by Jack W Callicutt, Chief Financial Officer at Galectin Therapeutics Inc, from SEC Form 4 filings since Mar 14, 2011.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +16%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 16, 2026 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Jan 16, 2026 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Jan 6, 2026 | GALT Galectin Therapeutics Inc | Sold | $74.7K |
| Jan 5, 2026 | GALT Galectin Therapeutics Inc | Sold | $100K |
| Jan 2, 2026 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Jan 2, 2026 | GALT Galectin Therapeutics Inc | Sold | $58.4K |
| Jan 1, 2026 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | $55.6K |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Sold | $175K |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | $20.2K |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Sold | $113K |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 18, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Sold | $57.8K |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Sold | $119K |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Sold | $14K |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 17, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Sold | $11.3K |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Sold | $10.1K |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Sold | $10.5K |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |
| Nov 10, 2025 | GALT Galectin Therapeutics Inc | Bought (not open market) | — |